CRTC2 polymorphism as a risk factor for the incidence of metabolic syndrome in patients with solid organ transplantation.

Quteineh, L.; Bochud, P.Y.; Golshayan, D.; Crettol, S.; Venetz, J.P.; Manuel, O.; Kutalik, Z.; Treyer, A.; Lehmann, R.; Mueller, N.J.; Binet, I.; van Delden, C.; Steiger, J.; Mohacsi, P.; Dufour, J.F.; Soccal, P.M.; Pascual, M.; Eap, C.B.

doi:10.1038/tpj.2015.82

CRTC2 polymorphism as a risk factor for the incidence of metabolic syndrome in patients with solid organ transplantation.

Details

Download: BIB_342B86B6E988.P001.pdf (742.52 [Ko])
State: Public
Version: Author's accepted manuscript

Serval ID

serval:BIB_342B86B6E988

Type

Article: article from journal or magazin.

Collection

Publications

Institution

UNIL/CHUV

Title

CRTC2 polymorphism as a risk factor for the incidence of metabolic syndrome in patients with solid organ transplantation.

Journal

The pharmacogenomics journal

Author(s)

Quteineh L., Bochud P.Y., Golshayan D., Crettol S., Venetz J.P., Manuel O., Kutalik Z., Treyer A., Lehmann R., Mueller N.J., Binet I., van Delden C., Steiger J., Mohacsi P., Dufour J.F., Soccal P.M., Pascual M., Eap C.B.

Working group(s)

and The Swiss Transplant Cohort Study

Contributor(s)

Achermann R., Aubert J.D., Baumann P., Beldi G., Benden C., Berger C., Binet I., Bochud P.Y., Boely E., Bucher H., Bühler L., Carell T., Catana E., Chalandon Y., Geest S., Rougemont O., Dickenmann M., Duchosal M., Fehr T., Ferrari-Lacraz S., Garzoni C., Gasche Y., Soccal P.G., Giostra E., Golshayan D., Good D., Hadaya K., Hess C., Hillinger S., Hirsch H., Hofbauer G., Huynh-Do U., Immer F., Klaghofer R., Koller M., Kuntzen T., Laesser B., Lehmann R., Lovis C., Manuel O., Marti H.P., Martin P.Y., Meylan P., Mohacsi P., Morard I., Morel P., Mueller U., Mueller N., Mueller-McKenna H., Müller T., Müllhaupt B., Nadal D., Nair G., Pascual M., Passweg J., Ziegler C.P., Rick J., Roosnek E., Rosselet A., Rothlin S., Ruschitzka F., Schanz U., Schaub S., Seiler C., Semmo N., Stampf S., Steiger J., Toso C., Tsinalis D., Delden C.V., Venetz J.P., Villard J., Wick M., Wilhelm M., Yerly P.

ISSN

1473-1150 (Electronic)

ISSN-L

1470-269X

Publication state

Published

Issued date

01/2017

Peer-reviewed

Oui

Volume

Number

Pages

69-75

Language

english

Notes

Publication types: Journal Article
Publication Status: ppublish

Abstract

Metabolic syndrome after transplantation is a major concern following solid organ transplantation (SOT). The CREB-regulated transcription co-activator 2 (CRTC2) regulates glucose metabolism. The effect of CRTC2 polymorphisms on new-onset diabetes after transplantation (NODAT) was investigated in a discovery sample of SOT recipients (n1=197). Positive results were tested for replication in two samples from the Swiss Transplant Cohort Study (STCS, n2=1294 and n3=759). Obesity and other metabolic traits were also tested. Associations with metabolic traits in population-based samples (n4=46'186, n5=123'865, n6>100,000) were finally analyzed. In the discovery sample, CRTC2 rs8450-AA genotype was associated with NODAT, fasting blood glucose and body mass index (Pcorrected<0.05). CRTC2 rs8450-AA genotype was associated with NODAT in the second STCS replication sample (odd ratio (OR)=2.01, P=0.04). In the combined STCS replication samples, the effect of rs8450-AA genotype on NODAT was observed in patients having received SOT from a deceased donor and treated with tacrolimus (n=395, OR=2.08, P=0.02) and in non-kidney transplant recipients (OR=2.09, P=0.02). Moreover, rs8450-AA genotype was associated with overweight or obesity (n=1215, OR=1.56, P=0.02), new-onset hyperlipidemia (n=1007, OR=1.76, P=0.007), and lower high-density lipoprotein-cholesterol (n=1214, β=-0.08, P=0.001). In the population-based samples, a proxy of rs8450G>A was significantly associated with several metabolic abnormalities. CRTC2 rs8450G>A appears to have an important role in the high prevalence of metabolic traits observed in patients with SOT. A weak association with metabolic traits was also observed in the population-based samples.

Keywords

Diabetes Mellitus/epidemiology, Diabetes Mellitus/genetics, Dyslipidemias/epidemiology, Dyslipidemias/genetics, Gene Frequency, Genetic Predisposition to Disease, Heterozygote, Homozygote, Humans, Incidence, Linear Models, Logistic Models, Metabolic Syndrome X/diagnosis, Metabolic Syndrome X/epidemiology, Metabolic Syndrome X/genetics, Multivariate Analysis, Obesity/epidemiology, Obesity/genetics, Odds Ratio, Organ Transplantation/adverse effects, Phenotype, Polymorphism, Single Nucleotide, Prevalence, Risk Assessment, Risk Factors, Switzerland/epidemiology, Time Factors, Transcription Factors/genetics, Treatment Outcome

URN

urn:nbn:ch:serval-BIB_342B86B6E9885

OAI-PMH

oai:serval.unil.ch:BIB_342B86B6E988

DOI

10.1038/tpj.2015.82

Pubmed

26644205

Web of science

000394462900011

Open Access

Yes